We are no longer accepting cases regarding these products. Due to a terrible Supreme Court ruling, consumers injured by this product are no longer permitted to sue the manufacturers of this device. We wish we could help, but the Supreme Court has taken the rights of citizens away to protect the profits of medical device manufacturers. For more information, please read the following New York Times article entitled “Medical Device Ruling Redraws Lines on Lawsuits.“
In 2005, a small study, the results of which were published in Journal of Gastrointestinal Surgery, found that LAP-BAND (Allergan) complication rates and reoperation rates were higher than for gastric bypass procedures and higher than the rates disclosed by the manufacturer on the warning label.
Allergan reported that 7 of 149 patients required reoperation, a rate of about 4.7%, while this study (by J.C. Jan, et al.) found that 31 of 154 (20%) of LAP-BAND patients required reoperation.
While gastric bypass and LAP-BAND had similar capacity to reduce excess weight, this study finding excess weight loss at 60% and 57% at three years, respectively, it is clear that these procedures do not come without risk: 18% of gastric bypass patients and 20% of LAP-BAND patients were found to suffer complications according to this study.